🇺🇸 FDA
Pipeline program

ADMSC-fib safety and efficacy in patients with chronico wounds

FJD-UHC-19-01

Phase 2 other active

Quick answer

ADMSC-fib safety and efficacy in patients with chronico wounds for chronic wounds is a Phase 2 program (other) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
chronic wounds
Phase
Phase 2
Modality
other
Status
active

Clinical trials